Skip to content
Medical Health Aged Care

Feedback invited from in-home aged care stakeholders to inform pricing advice

IHACPA 2 mins read

The Independent Health and Aged Care Pricing Authority (IHACPA) today released its Consultation Paper on the Pricing Approach for the Support at Home Service List 2025–26.

The Australian Government’s Support at Home program will combine existing in-home aged care services into a single, simplified program designed to assist older people to live independently at home for longer with the support services they require.

The Support at Home program will replace the Home Care Packages Program and Short-‑Term Restorative Care Programme from 1 July 2025. 

To support the development of independent in-home aged care pricing and costing advice to the government, IHACPA is seeking input on the proposed approach, methodology and principles to underpin this advice.

All stakeholders are invited to provide their feedback to help shape the development of IHACPA’s Support at Home pricing advice for 2025–26.

The consultation period is open to the public until 5pm AEDT 25 October 2024.

This year, IHACPA is seeking input on pricing policy principles, improvements to the representativeness of the cost collections, price benchmarking, methodology and adjustments, and priorities for future developments.

The consultation provides an opportunity for the aged care community, including older people living at home, their representatives and families, carers, aged care providers, governments, people working in aged care, and peak bodies, to provide their input on the factors that should be taken into consideration when developing pricing advice. This will support greater alignment of funding to the costs of delivering care.

The Pricing Authority Chair, Mr David Tune AO PSM said, ‘We want to listen to the issues that are important to the sector to build our understanding and ensure our advice results in the most accurate and fair pricing that reflects the true cost of delivering safe and quality in-home aged care services.’

‘Input from the aged care community will ensure our advice is representative of the diversity of aged care services, and meets the unique needs and challenges faced by in-home care recipients and providers,’ said Mr David Tune AO PSM.

As more information on the cost of delivering services becomes available, including through ongoing research and the input of stakeholders, IHACPA will refine its pricing advice and investigate future priorities.

The Department of Health and Aged Care will remain the system operators with overall responsibility for aged care policy, including the funding of in-home support services.

For media enquiries: contact communications.ihacpa@ihacpa.gov.au

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.